Efficacy of oral 5 mg melatonin in the treatment of facial melasma in women: A double‐blind, randomized, placebo‐controlled clinical trial
- 16 January 2024
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (7) , E607-E609
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Update on Melasma—Part II: TreatmentDermatology and Therapy, 2022
- Update on Melasma—Part I: PathogenesisDermatology and Therapy, 2022
- Revisiting the role of melatonin in human melanocyte physiology: A skin context perspectiveJournal of Pineal Research, 2022
- French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double‐blind, randomized, placebo‐controlled trialJournal of the European Academy of Dermatology and Venereology, 2020
- Melatonin and oxidative stress in melasma ‒ an unexplored territory; a prospective studyInternational Journal of Dermatology, 2020
- Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitroMolecular and Cellular Endocrinology, 2015
- Oxidative stress status in patients with melasmaCutaneous and Ocular Toxicology, 2013
- A Randomized, Double-Blinded, Placebo-Controlled Trial of OralPolypodium leucotomosExtract as an Adjunct to Sunscreen in the Treatment of MelasmaJAMA Dermatology, 2013
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersPLOS ONE, 2013
- Melatonin Antagonizes α‐Melanocyte‐Stimulating Hormone Enhancement of Melanogenesis in Mouse Melanoma Cells by Blocking the Hormone‐Induced Accumulation of the C Locus TyrosinaseEuropean Journal of Biochemistry, 1995